MEGALOTECT

Indications:

Prophylaxis of clinical manifestations of cytomegalovirus (CMV) infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.

Active Ingredient: CMV Immunoglobulin (Human)
Strength: 50 IU/ml
Volume: 10 ml, 20 ml, 50 ml
Method of Administration: Ready-to-use solution for intravenous injection